About
Ending Antibiotic Misuse. Clemedi is a paradigm shift Clemedi provides complete information to clinicians when most needed: early. It renders comprehensive information more quickly leading to faster, targeted therapy thus creating value. It will massively reduce the USD 11 digit direct and indirect cost of infectious diseases to patients, families, carers and society. It will revolutionize diagnostics and ultimately facilitate the end of antibiotic misuse.
Technologies
Mobile Friendly
WordPress.org
Woo Commerce
Nginx
Google Font API
IoT
Keywords
medtech
diagnostics
multiplex
infectious disease management
ion torrent s5 platform
multiplex pcr
smart software
tuberculosis detection
targeted diagnostics
personalized antibiotic therapy
laboratory reagents
drug susceptibility testing
pathogen identification
antimicrobial stewardship
research and development in the physical
engineering
and life sciences
dna sequencing
healthcare
mycobacterium tuberculosis dna extraction
bioinformatics analysis
drug resistance prediction
molecular diagnostics
services
sequencing-based tests
latent tuberculosis detection
resistance mutation profiling
medical diagnostics
rapid tb diagnosis
blood-based tb testing
Company Information
-
Employees 10
-
Founded 2019
-
Total Funding $20066
Location
12 Wagistrasse, Schlieren, Zurich, Switzerland, 8952
